{
    "title": "Will increasing vitamin D in blood to 100 ng reduce deaths of colon cancer patients",
    "slug": "will-increasing-vitamin-d-in-blood-to-100-ng-reduce-deaths-of-colon-cancer-patients",
    "aliases": [
        "/Will+increasing+vitamin+D+in+blood+to+100+ng+reduce+deaths+of+colon+cancer+patients-+July+2010",
        "/588"
    ],
    "tiki_page_id": 588,
    "date": "2010-07-08",
    "categories": [
        "How much Vitamin D",
        "Cancer - Colon"
    ],
    "tags": [
        "Cancer - Colon",
        "How much Vitamin D",
        "bacteria",
        "blood levels",
        "cancer",
        "colon cancer",
        "high dose",
        "pregnancy",
        "therapeutic intervention",
        "tuberculosis",
        "vitamin d",
        "vitamin d blood test"
    ]
}


<br />

<div align="center" class="indent3">

<h1>High Dose Vitamin D  Study - Clinical Trail registered July 2010</h1>

<div style="margin-top: 2ex; color: green;" class="header2">This study is not yet open for participant recruitment.</div>

<div>Verified by University of British Columbia, June 2010</div>

<div style="margin-top: 2ex;">First Received: June 22, 2010 &#160;           Last Updated: June 24, 2010 &#160;       <a on<x>click="openNewWindow('/ct2/archive/NCT01150877'); return

false;" title="Historical versions of study NCT01150877 on ClinicalTrials.gov

Archive Site" href="http://clinicaltrials.gov/ct2/archive/NCT01150877">History of Changes</a></div>

<table width="50%" cellspacing="0" cellpadding="5" border="1" style="margin: 2ex 0pt;" class="data_table">

<tbody>

<tr>

<th nowrap="nowrap" align="right" class="header3 pale_banner_color">Sponsor:</th>

<td nowrap="nowrap" align="left" class="body2">University of  British Columbia</td>

</tr>

<tr>

<th nowrap="nowrap" align="right" class="header3 pale_banner_color">Collaborator:</th>

<td nowrap="nowrap" align="left" class="body2">Lotte and John Hecht Memorial  Foundation</td>

</tr>

<tr>

<th nowrap="nowrap" align="right" class="header3 pale_banner_color">Information provided by:</th>

<td nowrap="nowrap" align="left" class="body2">University of  British Columbia</td>

</tr>

<tr>

<th nowrap="nowrap" align="right" class="header3 pale_banner_color">ClinicalTrials.gov Identifier:</th>

<td nowrap="nowrap" align="left" class="body2">NCT01150877</td>

</tr>

</tbody>

</table>

</div>

<!-- purpose_section -->

<div style="margin-top: 3ex;" class="indent1"><img src="http://clinicaltrials.gov/ct2/html/images/frame/triangle.gif" alt="image" width="16" height="15"><span class="header2">&#160; Purpose</span>

<div style="margin-top: 2ex;" class="indent2">

<div class="body3">

<p style="margin-bottom: 1ex;">The purpose of this  study is to investigate the therapeutic effect and the safety of  high-dose vitamin D supplementation in metastatic colorectal cancer  patients. We propose to supplement metastatic (stage 4) colorectal  cancer patients with oral doses of vitamin D to raise serum  25-hydroxy-vitamin D <span>[25(OH)D]</span> levels to the high normal range of  200-250 nmol/L. The primary objective of this study is to evaluate the  metabolic consequences, including tolerability and toxicity, of  prolonged, high-dose physiological vitamin D in patients with colorectal  cancer. The secondary objective is to evaluate patient survival with  regards to high-dose vitamin D supplementation.</p>

<p style="margin-bottom: 1ex;">Hypothesis:</p>

<p style="margin-bottom: 1ex;">Whereas low doses of vitamin D reportedly  play a significant role in prevention of colorectal cancers, do much  larger (pharmacological) doses of vitamin D have a significant  therapeutic effect against the same kind of cancer?</p>

</div>

<br />

<!-- condition, intervention, phase summary table -->

<div align="center">

<table width="80%" cellspacing="0" cellpadding="5" border="1" class="data_table">

<tbody>

<tr align="left">

<th class="header3 pale_banner_color"><a on<x>click="openPopupWindow('/ct2/help/conditions_desc',false); return

false;" title="Help on Conditions field" href="http://clinicaltrials.gov/ct2/help/conditions_desc">Condition</a></th>

<th class="header3 pale_banner_color"><a on<x>click="openPopupWindow('/ct2/help/interventions_desc',false); return

false;" title="Help on Interventions field" href="http://clinicaltrials.gov/ct2/help/interventions_desc">Intervention</a></th>

<th class="header3 pale_banner_color"><a on<x>click="openPopupWindow('/ct2/help/phase_desc',false); return false;" title="Help on Phase field" href="http://clinicaltrials.gov/ct2/help/phase_desc">Phase</a></th>

</tr>

<tr valign="top" align="left">

<td nowrap="nowrap" class="body3">Colorectal Cancer</td>

<td nowrap="nowrap" class="body3">Drug: Vitamin D</td>

<td nowrap="nowrap" class="body3">Phase I<br />

Phase II</td>

</tr>

</tbody>

</table>

</div>

<br />

<table cellspacing="0" cellpadding="0" border="0" style="margin-bottom: 2ex;" class="layout_table">

<tbody>

<tr valign="top">

<td nowrap="nowrap">Study Type:</td>

<td style="padding-left: 1em;">Interventional</td>

</tr>

<tr valign="top">

<td nowrap="nowrap">Study Design:</td>

<td style="padding-left: 1em;">Allocation:&#160;Randomized<br />

Control:&#160;Active&#160;Control<br />

Endpoint&#160;Classification:&#160;Safety/Efficacy&#160;Study<br />

Intervention&#160;Model:&#160;Parallel&#160;Assignment<br />

Masking:&#160;Open&#160;Label<br />

Primary&#160;Purpose:&#160;Treatment</td>

</tr>

<tr valign="top">

<td nowrap="nowrap" style="padding-top: 2ex;">Official Title:</td>

<td style="padding-left: 1em; padding-top: 2ex;">Study of  High-dose Vitamin D Supplementation in Stage-4 Colorectal Cancer  Patients</td>

</tr>

</tbody>

</table>

<!-- NLM links -->   <br />

<div class="header3">Resource links provided by NLM:</div>

<br />

<div class="indent3"><!-- medline links -->

<div style="margin-bottom: 2ex;"><a on<x>click="openNewWindow('http://www.nlm.nih.gov/medlineplus/');

return false" title="MedlinePlus

site" href="http://www.nlm.nih.gov/medlineplus/">MedlinePlus</a> related topics:             <a on<x>click="openNewWindow('/ct2/bye/uQoPWw4lZX-i-iSxudhWudNzlXNiZip9m67PvQ7xzwhaLwS90B7x061nuQoPmdt.');

return false" title="Cancer at MedlinePlus site" href="http://clinicaltrials.gov/ct2/bye/uQoPWw4lZX-i-iSxudhWudNzlXNiZip9m67PvQ7xzwhaLwS90B7x061nuQoPmdt." style="padding-left: 0.5em;">Cancer</a>                 <a on<x>click="openNewWindow('/ct2/bye/OQoPWw4lZX-i-iSxudhWudNzlXNiZip9m67PvQ7xzwhaLwS90dcaZwNH0ihGvBcGuBcHSXNkWd7E.');

return false" title="Colorectal&#160;Cancer at MedlinePlus site" href="http://clinicaltrials.gov/ct2/bye/OQoPWw4lZX-i-iSxudhWudNzlXNiZip9m67PvQ7xzwhaLwS90dcaZwNH0ihGvBcGuBcHSXNkWd7E." style="padding-left: 0.5em;">Colorectal&#160;Cancer</a>                 <a on<x>click="openNewWindow('/ct2/bye/rQoPWw4lZX-i-iSxudhWudNzlXNiZip9m67PvQ7xzwhaLwS95Q7HWB1yxw-HEwhazd7HuioRuQoPmdt.');

return false" title="Dietary&#160;Supplements at MedlinePlus site" href="http://clinicaltrials.gov/ct2/bye/rQoPWw4lZX-i-iSxudhWudNzlXNiZip9m67PvQ7xzwhaLwS95Q7HWB1yxw-HEwhazd7HuioRuQoPmdt." style="padding-left: 0.5em;">Dietary&#160;Supplements</a>                 <a on<x>click="openNewWindow('/ct2/bye/EQoPWw4lZX-i-iSxudhWudNzlXNiZip9m67PvQ7xzwhaLwS9cQ1Pkd7zu6YxlihLv.');

return false" title="Vitamin&#160;D at MedlinePlus site" href="http://clinicaltrials.gov/ct2/bye/EQoPWw4lZX-i-iSxudhWudNzlXNiZip9m67PvQ7xzwhaLwS9cQ1Pkd7zu6YxlihLv." style="padding-left: 0.5em;">Vitamin&#160;D</a></div>

<!-- SIS links -->

<div style="margin-bottom: 2ex;"><a on<x>click="openNewWindow('http://druginfo.nlm.nih.gov/drugportal/drugportal.jsp');

return false" title="Drug Information Portal" href="http://druginfo.nlm.nih.gov/drugportal/drugportal.jsp">Drug Information</a> available for:             <a on<x>click="openNewWindow('/ct2/bye/YQoPWw4lZXcPSi7iedN6ZXNxvdDxuQ7Ju6c9cXcPSi7iEd-yWB7EZ6o35Q1yzB-VuQUgEscxkd789HNzWB7Ledpmj.');

return false" title="Vitamin&#160;D at ChemIDplus site" href="http://clinicaltrials.gov/ct2/bye/YQoPWw4lZXcPSi7iedN6ZXNxvdDxuQ7Ju6c9cXcPSi7iEd-yWB7EZ6o35Q1yzB-VuQUgEscxkd789HNzWB7Ledpmj." style="padding-left: 0.5em;">Vitamin&#160;D</a></div>

<div style="margin-bottom: 2ex;"><a on<x>click="openNewWindow('/ct2/info/fdalinks'); return

false" title="Show

FDA resources page" href="http://clinicaltrials.gov/ct2/info/fdalinks">U.S. FDA Resources</a></div>

</div>

<!-- more details -->   <br />

<div class="header3">Further study details as provided by University  of British Columbia:</div>

<br />

<div class="indent3"><!-- primary outcomes -->

<div class="body3">Primary Outcome Measures:

<ul style="margin-top: 1ex; margin-bottom: 1ex;">

<li style="margin-top: 0.7ex;">The metabolic consequences,  including tolerability and toxicity, of prolonged, high-dose  physiological vitamin D in patients with colorectal cancer.  <span>[&#160;Time&#160;Frame:&#160;After 16 months of intervention&#160;]</span>  <span>[&#160;Designated&#160;as&#160;safety&#160;issue:&#160;No&#160;]</span></li>

<li style="margin-top: 0.7ex;">The metabolic  consequences, including tolerability and toxicity, of prolonged,  high-dose physiological vitamin D in patients with colorectal cancer.  <span>[&#160;Time&#160;Frame:&#160;After 12 months of follow-up&#160;]</span>  <span>[&#160;Designated&#160;as&#160;safety&#160;issue:&#160;No&#160;]</span></li>

</ul>

</div>

<br />

<!-- secondary outcomes -->

<div class="body3">Secondary Outcome Measures:

<ul style="margin-top: 1ex; margin-bottom: 1ex;">

<li style="margin-top: 0.7ex;">Patient survival with regards  to high-dose vitamin D supplementation. <span>[&#160;Time&#160;Frame:&#160;After 16 months  of intervention&#160;]</span> <span>[&#160;Designated&#160;as&#160;safety&#160;issue:&#160;No&#160;]</span></li>

<li style="margin-top: 0.7ex;">Patient survival with  regards to high-dose vitamin D supplementation. <span>[&#160;Time&#160;Frame:&#160;After 12  months of follow-up&#160;]</span> <span>[&#160;Designated&#160;as&#160;safety&#160;issue:&#160;No&#160;]</span></li>

</ul>

</div>

<br />

<table cellspacing="0" cellpadding="0" border="0" style="margin-bottom: 3ex;" class="layout_table">

<tbody>

<tr valign="top">

<td nowrap="nowrap">Estimated  Enrollment:</td>

<td style="padding-left: 1em;">40</td>

</tr>

<tr valign="top">

<td nowrap="nowrap">Study Start Date:</td>

<td style="padding-left: 1em;">January 2011</td>

</tr>

<tr valign="top">

<td nowrap="nowrap">Estimated  Study Completion Date:</td>

<td style="padding-left: 1em;">October 2013</td>

</tr>

<tr valign="top">

<td nowrap="nowrap">Estimated  Primary Completion Date:</td>

<td style="padding-left: 1em;">July 2013 (Final data collection  date for primary outcome measure)</td>

</tr>

</tbody>

</table>

<!-- arms and groups table -->

<div align="center">

<table width="100%" cellspacing="0" cellpadding="5" border="1" class="data_table">

<tbody>

<tr align="left">

<th class="header3 pale_banner_color"><a on<x>click="openPopupWindow('/ct2/help/arm_group_desc',false); return

false;" title="Help on Arm Group field" href="http://clinicaltrials.gov/ct2/help/arm_group_desc">              Arms           </a></th>

<th class="header3 pale_banner_color"><a on<x>click="openPopupWindow('/ct2/help/interventions_desc',false); return

false;" title="Help

on Interventions field" href="http://clinicaltrials.gov/ct2/help/interventions_desc">             Assigned Interventions           </a></th>

</tr>

<tr valign="top" align="left">

<td class="body3">Experimental Dietary Supplement (e.g., vitamins, minerals):  Experimental

<div style="margin: 0.5ex 0.5ex 0.5ex 4ex;">Experimental arm is supplemented with high-dose of vitamin D.</div>

</td>

<td class="body3">Drug: Vitamin D

<div style="margin: 0.5ex 0.5ex 0.5ex 4ex;">We propose to study high-dose, oral vitamin D supplementation,  raising serum 25-hydroxy-vitamin D (25(OH)D) concentrations to <strong>200 -250  nmol/L, i</strong>n metastatic colorectal cancer patients with safety,  tolerability and survival as the main outcome measurements. The dose is  not pre-set and will depend on the individual subjects' serum 25(OH)D  concentration. Subjects will be supplemented for 16 months with a daily  oral dose, followed by a 12 months follow-up period.</div>

</td>

</tr>

<tr valign="top" align="left">

<td class="body3">No Intervention: No Intervention</td>

<td class="body3">&#160;</td>

</tr>

</tbody>

</table>

</div>

<br />

<a id="desc" name="desc"></a>                    <!-- detailed description -->     <span class="header3">Detailed Description:</span>

<div class="body3">

<p style="margin-bottom: 1ex;">Metastatic (stage  4) colorectal cancer patients who were randomly assigned to the  treatment arm of this study will be orally supplemented with high doses  of vitamin D to achieve serum 25(OH)D concentrations of 200-250 nmol/L  (80-100 ng/ml). Therefore, the supplementation dosage is not pre-set but  will be determined on an individual basis. Vitamin D supplementation  will be continued for 16 months, followed by a 12 month follow up  period. Monthly monitoring of serum 25(OH)D and calcium levels will  assure the safety of our treatment protocol. Subjects in the control arm  of the study will be receiving standard cancer care at InspireHealth  that includes supplementation with at least 2,000 International Units of  vitamin D.</p>

</div>

</div>

</div>

</div>

<!-- eligibility_section -->

<div style="margin-top: 3ex; border: 1px solid white;" class="indent1"><img src="http://clinicaltrials.gov/ct2/html/images/frame/triangle.gif" alt="image" width="16" height="15"><span class="header2">&#160; Eligibility</span><br />

<br />

<div class="indent2">

<table cellspacing="0" cellpadding="0" border="0" class="layout_table">

<tbody>

<tr>

<td nowrap="nowrap">Ages Eligible for Study: &#160;</td>

<td style="padding-left: 1em;">18 Years and older</td>

</tr>

<tr>

<td nowrap="nowrap">Genders Eligible for Study: &#160;</td>

<td style="padding-left: 1em;">Both</td>

</tr>

<tr>

<td nowrap="nowrap">Accepts Healthy Volunteers: &#160;</td>

<td style="padding-left: 1em;">No</td>

</tr>

</tbody>

</table>

<div style="margin-top: 2ex;" class="header3">Criteria</div>

<div class="indent2">

<p style="margin-bottom: 1ex;">Inclusion  Criteria (We will recruit stage 4 (metastatic) colorectal cancer  patients who are clients at InspireHealth):</p>

<ul style="margin-top: 1ex; margin-bottom: 1ex;">

<li style="margin-top: 0.7ex;">Age > 18</li>

<li style="margin-top: 0.7ex;">Histologically confirmed colon or rectal  cancer</li>

<li style="margin-top: 0.7ex;">Known metastatic disease (stage-4)  confirmed histologically or radiologically</li>

<li style="margin-top: 0.7ex;">Life expectancy of >8 months</li>

<li style="margin-top: 0.7ex;">May receive anti-neoplastic therapy at  the discretion of their physician</li>

<li style="margin-top: 0.7ex;">Stable metastatic disease defined as no  change in systemic for the month before and the month after commencing  study</li>

<li style="margin-top: 0.7ex;">Signed informed consent</li>

</ul>

<p style="margin-bottom: 1ex;">Exclusion Criteria(Stage 4 colorectal  cancer patients):</p>

<ul style="margin-top: 1ex; margin-bottom: 1ex;">

<li style="margin-top: 0.7ex;">Pregnant / lactating women</li>

<li style="margin-top: 0.7ex;">Known hypersensitivity to vitamin D</li>

<li style="margin-top: 0.7ex;">Pre-existing renal stone disease based on  history</li>

<li style="margin-top: 0.7ex;">Pre-existing hypercalcemia</li>

<li style="margin-top: 0.7ex;">Severe renal or hepatic dysfunction (? 2x  of the upper normal range)</li>

<li style="margin-top: 0.7ex;">granulomatous disease (TB and sarcoid)</li>

<li style="margin-top: 0.7ex;">unable to give informed consent in  English (translations of study documents in languages other than English  will not be provided)</li>

</ul>

</div>

</div>

</div>

<!-- location_section -->

<div style="margin-top: 3ex;" class="indent1"><img src="http://clinicaltrials.gov/ct2/html/images/frame/triangle.gif" alt="image" width="16" height="15"><span class="header2">&#160; Contacts and Locations</span><br />

<div style="margin-top: 2ex;" class="indent2">Please refer to this study by its ClinicalTrials.gov identifier:  NCT01150877<br />

<br />

<!-- contacts -->

<div style="margin-top: 2ex;" class="header3">Contacts</div>

<table cellspacing="0" cellpadding="0" border="0" class="layout_table indent2">

<tbody>

<tr>

<td nowrap="nowrap" style="padding: 1ex 1em 0px 0px;">Contact:  Julius Halaschek-Wiener, PhD</td>

<td nowrap="nowrap" style="padding: 1ex 1em 0px 0px;">604-734-7125</td>

<td nowrap="nowrap" style="padding: 1ex 1em 0px 0px;"><a href="mailto:jhalaschek-wiener%40inspirehealth.ca?subject=NCT01150877,%20H10-00028,%20High%20Dose%20Vitamin%20D%20Study">jhalaschek-wiener@inspirehealth.ca</a></td>

</tr>

</tbody>

</table>

<br />

<!-- locations -->   <a id="locn" name="locn"></a>

<div style="margin-top: 2ex;" class="header3">Locations</div>

<table cellspacing="0" cellpadding="0" border="0" class="layout_table indent2">

<tbody>

<tr>

<td nowrap="nowrap" style="padding-top: 2ex;" class="header3" colspan="2">Canada, British Columbia</td>

</tr>

<tr>

<td nowrap="nowrap" style="padding: 1ex 1em 0px 2em;">InspireHealth</td>

</tr>

<tr>

<td nowrap="nowrap" style="padding-left: 4em;" colspan="2">Vancouver,  British Columbia, Canada, V6H 4A6</td>

</tr>

</tbody>

</table>

<!-- sponsors -->

<div style="margin-top: 2ex;" class="header3">Sponsors and  Collaborators</div>

<div style="margin-top: 1ex;" class="indent2">University of British  Columbia</div>

<div style="margin-top: 1ex;" class="indent2">Lotte and John Hecht  Memorial Foundation</div>

<!-- investigators -->

<div style="margin-top: 2ex;" class="header3">Investigators</div>

<table cellspacing="0" cellpadding="0" border="0" class="layout_table indent2">

<tbody>

<tr>

<td nowrap="nowrap" style="padding: 1ex 1em 0px 0px;">Principal  Investigator:</td>

<td nowrap="nowrap" style="padding: 1ex 1em 0px 0px;">Hal Gunn, MD</td>

<td nowrap="nowrap" style="padding: 1ex 1em 0px 0px;">University  of British Columbia</td>

</tr>

</tbody>

</table>

</div>

</div>

<!-- more_info_section -->  <img src="http://clinicaltrials.gov/ct2/html/images/frame/triangle.gif" alt="image" width="16" height="15"><span class="header2">&#160; More Information</span>     <br />

Additional Information:

<div style="margin-top: 2ex;" class="indent2"><a on<x>click="openNewWindow('/ct2/bye/dQoPWw4lZX-i-iSxedUgEQ1yzQhHkdoPlXNgk/R8NHvB1Pz6Y3ydN6Z');

return false" title="Related Info" href="http://clinicaltrials.gov/ct2/bye/dQoPWw4lZX-i-iSxedUgEQ1yzQhHkdoPlXNgk/R8NHvB1Pz6Y3ydN6Z">Related Info</a>&#160;     <img src="http://clinicaltrials.gov/ct2/html/images/frame/exit.bmp" alt="This" width="18" height="10"></div>

<br />

No publications provided <br />

<br />

<table cellspacing="0" cellpadding="0" border="0" style="margin-top: 1ex;" class="layout_table">

<tbody>

<tr valign="top">

<td nowrap="nowrap">Responsible Party:</td>

<td style="padding-left: 1em;">University of British Columbia (  Dr. Hal Gunn )</td>

</tr>

<tr valign="top">

<td nowrap="nowrap">ClinicalTrials.gov Identifier:</td>

<td style="padding-left: 1em;"><a href="http://clinicaltrials.gov/ct2/show/NCT01150877" title="Current version of study NCT01150877 on

ClinicalTrials.gov">NCT01150877</a> &#160; &#160;         <a on<x>click="openNewWindow('/ct2/archive/NCT01150877'); return

false;" title="Historical versions of study NCT01150877 on ClinicalTrials.gov

Archive Site" href="http://clinicaltrials.gov/ct2/archive/NCT01150877">History of Changes</a></td>

</tr>

<tr valign="top">

<td nowrap="nowrap">Other Study ID Numbers:</td>

<td style="padding-left: 1em;">H10-00028</td>

</tr>

<tr valign="top">

<td nowrap="nowrap">Study First Received:</td>

<td style="padding-left: 1em;">June 22, 2010</td>

</tr>

<tr valign="top">

<td nowrap="nowrap">Last Updated:</td>

<td style="padding-left: 1em;">June 24, 2010</td>

</tr>

<tr valign="top">

<td nowrap="nowrap">Health Authority:</td>

<td style="padding-left: 1em;">Canada: Health Canada</td>

</tr>

</tbody>

</table>

<!-- keywords -->     <br />

Keywords provided by University of British Columbia:

<div class="indent3">

<table width="100%" cellspacing="0" cellpadding="0" border="0" class="layout_table">

<tbody>

<tr valign="top">

<td width="50%">Vitamin D<br />

Vitamin D3<br />

colon cancer<br />

rectal cancer<br />

Cholecalciferol</td>

</tr>

</tbody>

</table>

</div>

<!-- mesh terms -->     <br />

Additional relevant MeSH terms:

<div class="indent3">

<table width="100%" cellspacing="0" cellpadding="0" border="0" class="layout_table">

<tbody>

<tr valign="top">

<td width="50%">Digestive System Neoplasms<br />

Gastrointestinal Diseases<br />

Growth Substances<br />

Physiological Effects of Drugs<br />

Colonic Diseases<br />

Ergocalciferols<br />

Bone Density Conservation Agents<br />

Intestinal Diseases<br />

Rectal Diseases<br />

Pharmacologic Actions</td>

<td width="50%" style="padding-left: 1em;">Intestinal Neoplasms<br />

Neoplasms<br />

Neoplasms by Site<br />

Digestive System Diseases<br />

Vitamin D<br />

Vitamins<br />

Gastrointestinal Neoplasms<br />

Micronutrients<br />

Colorectal Neoplasms</td>

</tr>

</tbody>

</table>

</div>

<br />

<span class="body3">ClinicalTrials.gov processed this record on July  07, 2010</span><br />

<br />